𝔖 Bobbio Scriptorium

✦ LIBER ✦

123 A sensitive and accurate assay system for the screening of antiviral compounds against herpes simplex virus type 1 and type 2: Kenji Sudo1), Kenji Konno1), Tomoyuki Yokota1) and Siro Shigeta2), Rational Drug Design Laboratories1), Fukushima 960-12 and Department of Microbiology, Fukushima Medical College2), Fukushima 960-12, Japan

Book ID: 118393192
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 75 KB
Volume: 20
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(93)90501-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

124 Susceptibility of HCMV clinical isol

124 Susceptibility of HCMV clinical isolates to ganciclovir (GCV) and hpmpc: Kenji Konno1, Tomoyuki Yokota1, Masanori Baba2 and Shiro Shigeta2. Rational Drug Design Laboratories1, Fukushima (960-12) and Department of Microbiology, Fukushima Medical College2, Fukushima (960-12), Japan

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 73 KB

203 Establishment of a highly sensitive

203 Establishment of a highly sensitive assay system for screening of anti-orthomyxo- and-paramyxoviruses agents: Wataru Watanabe∗, Kenji Konno∗, Tomoyuki Yokota∗ and Shiro Shigeta∗∗. ∗Rational Drug Design Laboratories, Fukushima (960-12) and ∗∗Department of Microbiology, Fukushima Medical College, Fukushima (960-12), Japan

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 81 KB

115 Uracil incorporation into thymidine

115 Uracil incorporation into thymidine kinase deficient varicella-zoster virus dna: Tomoyuki YOKOTA1), Kennji KONNO1), Shuichi MORI2) and Shiro SIGETA2) 1)Rational Drug Design Laboratories, 4-1-1, Misato-Matukawa, Fukushima, 960-12, 2)Department of Microbiology, Fukushima Medical College, Fukushima, 960-12, Japan

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Establishment of an in vitro assay syste

Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography: Kenji Sudo1,3, Hiroshi Inoue1, Yasuaki Shimizu2, Kayo Yamaji2, Kenji Konno1, Shiro Shigeta3, Takashi Kaneko4, Tomoyuki Yokota1, and Kunitada Shimotohno4, Rational Drug Design Laboratories1, Fukushima 960-12, Molecular Medicine Research Laboratories, Yamanouchi Pharmaceutical Co. Ltd.2, Tsukuba-shi, Ibaraki 305, Department of Microbiology, Fukushima Medical College3, Fukushima 960-12, Virology Division, National Cancer Center Research Institute4, Tokyo 104, Japan

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 113 KB